ALX Oncology Statistics
NASDAQ: ALXOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.27+0.085 (+7.20%)
Market open · Delayed 15 min · as of Oct 9, 3:33 PM ET
ALX Oncology by the numbers
ALX Oncology has a market capitalization of $174.9 million based on 138.28M shares outstanding. With trailing EPS of $-1.13, ALX Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 29.2% below its 50-day average and 31.1% below its 200-day average.
Average daily trading volume is 1.04M shares, or about $1.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALXO valuation vs. peer median
| Metric | ALXO | Peer median | Difference |
|---|---|---|---|
| Market cap | $174.92M | $162.21M | +8% |
| Avg. volume | 1.04M | 311.60K | +234% |
Peer median across 8 companies: NBP, EMIS, ORGO, NKTX, MSLE, CNTN, ANTX, MENS.
Valuation
- Market cap
- $174.92M
- EPS (TTM)
- $-1.13
- Shares outstanding
- 138.28M
Price and trading
- Previous close
- 1.18
- Open
- 1.16
- Day range
- 1.15 – 1.29
- 52-week range
- 1.05 – 2.66
- 52-week change
- -40.10%
- Beta
- —
- Volume
- 826.04K
- Average volume
- 1.04M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 174.92M
- Forward Pe
- -2.35
- Eps
- -1.13
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.66
- Week52 Low
- 1.05
- Avg Volume
- 1.04M
- Shares Outstanding
- 138.28M
- Ma50
- 1.79
- Ma200
- 1.84
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -52.44%
- Pct From52w Low
- 20.48%